Literature DB >> 18770611

Genetic manipulation of Porphyromonas gingivalis.

Myriam Bélanger1, Paulo Rodrigues, Ann Progulske-Fox.   

Abstract

Porphyromonas gingivalis, an oral anaerobic bacterium, is an important etiological agent of periodontal disease and may contribute to cardiovascular disease, preterm birth, and diabetes as well. Therefore, genetic studies are of crucial importance in investigating molecular mechanisms of P. gingivalis virulence. Although molecular genetic tools have been available for many bacterial species for some time, genetic manipulations of Porphyromonas species were not developed until more recently and remain limited. In this unit, current molecular genetic approaches for mutant construction in P. gingivalis using the suicide vector pPR-UF1 and the transposon Tn4351 are described, as are protocols for performing electroporation and conjugation. Furthermore, a technique to restore the wild-type phenotype of the mutant by complementation using vector pT-COW is provided. Finally, a description of a noninvasive reporter system allowing the study of gene expression and regulation in P. gingivalis completes this unit.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18770611     DOI: 10.1002/9780471729259.mc13c02s05

Source DB:  PubMed          Journal:  Curr Protoc Microbiol


  21 in total

1.  Defining essential genes and identifying virulence factors of Porphyromonas gingivalis by massively parallel sequencing of transposon libraries (Tn-seq).

Authors:  Brian A Klein; Margaret J Duncan; Linden T Hu
Journal:  Methods Mol Biol       Date:  2015

2.  Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems.

Authors:  Michał Burmistrz; Bartosz Dudek; Dominika Staniec; Jose Ignacio Rodriguez Martinez; Matthias Bochtler; Jan Potempa; Krzysztof Pyrc
Journal:  J Bacteriol       Date:  2015-05-26       Impact factor: 3.490

3.  Analysis of a band 7/MEC-2 family gene of Porphyromonas gingivalis.

Authors:  S Walters; P Rodrigues; M Bélanger; J Whitlock; A Progulske-Fox
Journal:  J Dent Res       Date:  2009-01       Impact factor: 6.116

4.  Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs in the Porphyromonas gingivalis CRISPR-Cas I-C System.

Authors:  Michal Burmistrz; Jose Ignacio Rodriguez Martinez; Daniel Krochmal; Dominika Staniec; Krzysztof Pyrc
Journal:  J Bacteriol       Date:  2017-10-31       Impact factor: 3.490

Review 5.  Genetic diversity in the oral pathogen Porphyromonas gingivalis: molecular mechanisms and biological consequences.

Authors:  Gena D Tribble; Jennifer E Kerr; Bing-Yan Wang
Journal:  Future Microbiol       Date:  2013-05       Impact factor: 3.165

6.  A member of the peptidase M48 superfamily of Porphyromonas gingivalis is associated with virulence in vitro and in vivo.

Authors:  Sheila Walters; Myriam Bélanger; Paulo H Rodrigues; Joan Whitlock; Ann Progulske-Fox
Journal:  J Oral Microbiol       Date:  2009-11-25       Impact factor: 5.474

7.  Genomic comparison of invasive and rare non-invasive strains reveals Porphyromonas gingivalis genetic polymorphisms.

Authors:  Svetlana Dolgilevich; Brian Rafferty; Darya Luchinskaya; Emil Kozarov
Journal:  J Oral Microbiol       Date:  2011-03-09       Impact factor: 5.474

8.  Structure, function, and inhibition of a genomic/clinical variant of Porphyromonas gingivalis peptidylarginine deiminase.

Authors:  Grzegorz Bereta; Theodoros Goulas; Mariusz Madej; Ewa Bielecka; Maria Solà; Jan Potempa; F Xavier Gomis-Rüth
Journal:  Protein Sci       Date:  2019-01-30       Impact factor: 6.993

9.  The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts.

Authors:  Jorg Brunner; Nina Scheres; Nawal B El Idrissi; Dong M Deng; Marja L Laine; Arie J van Winkelhoff; Wim Crielaard
Journal:  BMC Microbiol       Date:  2010-01-11       Impact factor: 3.605

10.  Porphyromonas gingivalis strain specific interactions with human coronary artery endothelial cells: a comparative study.

Authors:  Paulo H Rodrigues; Leticia Reyes; Amandeep S Chadda; Myriam Bélanger; Shannon M Wallet; Debra Akin; William Dunn; Ann Progulske-Fox
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.